CONMED CORP (CNMD) Stock Fundamental Analysis
USA - NYSE:CNMD - US2074101013 - Common Stock
47.11 USD
-0.25 (-0.53%)
Taking everything into account, CNMD scores 6 out of 10 in our fundamental rating. CNMD was compared to 189 industry peers in the Health Care Equipment & Supplies industry. CNMD scores excellent on profitability, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on CNMD.
1. Profitability
1.1 Basic Checks
CNMD had positive earnings in the past year.
In the past year CNMD had a positive cash flow from operations.
Of the past 5 years CNMD 4 years were profitable.
In the past 5 years CNMD always reported a positive cash flow from operatings.
1.2 Ratios
CNMD's Return On Assets of 4.73% is amongst the best of the industry. CNMD outperforms 80.95% of its industry peers.
The Return On Equity of CNMD (10.99%) is better than 86.77% of its industry peers.
CNMD has a Return On Invested Capital of 7.55%. This is amongst the best in the industry. CNMD outperforms 83.60% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CNMD is below the industry average of 9.01%.
The last Return On Invested Capital (7.55%) for CNMD is above the 3 year average (5.34%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.73% | ||
| ROE | 10.99% | ||
| ROIC | 7.55% |
ROA(3y)1.68%
ROA(5y)1.82%
ROE(3y)3.56%
ROE(5y)3.99%
ROIC(3y)5.34%
ROIC(5y)4.97%
1.3 Margins
CNMD has a Profit Margin of 8.31%. This is amongst the best in the industry. CNMD outperforms 80.95% of its industry peers.
CNMD's Profit Margin has improved in the last couple of years.
The Operating Margin of CNMD (14.38%) is better than 83.07% of its industry peers.
CNMD's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 56.05%, CNMD perfoms like the industry average, outperforming 52.38% of the companies in the same industry.
CNMD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.38% | ||
| PM (TTM) | 8.31% | ||
| GM | 56.05% |
OM growth 3Y13.68%
OM growth 5Y9.55%
PM growth 3Y17.89%
PM growth 5Y27.61%
GM growth 3Y-0.07%
GM growth 5Y0.25%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CNMD is still creating some value.
The number of shares outstanding for CNMD has been increased compared to 1 year ago.
Compared to 5 years ago, CNMD has more shares outstanding
The debt/assets ratio for CNMD has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.04 indicates that CNMD is not a great score, but indicates only limited risk for bankruptcy at the moment.
CNMD's Altman-Z score of 2.04 is in line compared to the rest of the industry. CNMD outperforms 59.26% of its industry peers.
The Debt to FCF ratio of CNMD is 5.95, which is a neutral value as it means it would take CNMD, 5.95 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CNMD (5.95) is better than 78.31% of its industry peers.
A Debt/Equity ratio of 0.88 indicates that CNMD is somewhat dependend on debt financing.
CNMD's Debt to Equity ratio of 0.88 is on the low side compared to the rest of the industry. CNMD is outperformed by 74.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.88 | ||
| Debt/FCF | 5.95 | ||
| Altman-Z | 2.04 |
ROIC/WACC1.19
WACC6.37%
2.3 Liquidity
A Current Ratio of 2.23 indicates that CNMD has no problem at all paying its short term obligations.
CNMD's Current ratio of 2.23 is in line compared to the rest of the industry. CNMD outperforms 41.27% of its industry peers.
A Quick Ratio of 1.00 indicates that CNMD should not have too much problems paying its short term obligations.
CNMD has a Quick ratio of 1.00. This is in the lower half of the industry: CNMD underperforms 75.66% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.23 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 20.38% over the past year.
Measured over the past years, CNMD shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.44% on average per year.
CNMD shows a small growth in Revenue. In the last year, the Revenue has grown by 3.94%.
CNMD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.47% yearly.
EPS 1Y (TTM)20.38%
EPS 3Y9.03%
EPS 5Y9.44%
EPS Q2Q%17.35%
Revenue 1Y (TTM)3.94%
Revenue growth 3Y8.95%
Revenue growth 5Y6.47%
Sales Q2Q%3.09%
3.2 Future
Based on estimates for the next years, CNMD will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.42% on average per year.
Based on estimates for the next years, CNMD will show a small growth in Revenue. The Revenue will grow by 5.42% on average per year.
EPS Next Y9.58%
EPS Next 2Y8.14%
EPS Next 3Y9.42%
EPS Next 5YN/A
Revenue Next Year5.05%
Revenue Next 2Y5.25%
Revenue Next 3Y5.42%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.49, the valuation of CNMD can be described as very reasonable.
CNMD's Price/Earnings ratio is rather cheap when compared to the industry. CNMD is cheaper than 93.12% of the companies in the same industry.
When comparing the Price/Earnings ratio of CNMD to the average of the S&P500 Index (27.08), we can say CNMD is valued rather cheaply.
The Price/Forward Earnings ratio is 9.68, which indicates a very decent valuation of CNMD.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CNMD indicates a rather cheap valuation: CNMD is cheaper than 94.18% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.09, CNMD is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.49 | ||
| Fwd PE | 9.68 |
4.2 Price Multiples
CNMD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CNMD is cheaper than 92.59% of the companies in the same industry.
96.30% of the companies in the same industry are more expensive than CNMD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.84 | ||
| EV/EBITDA | 8.78 |
4.3 Compensation for Growth
CNMD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of CNMD may justify a higher PE ratio.
PEG (NY)1.1
PEG (5Y)1.11
EPS Next 2Y8.14%
EPS Next 3Y9.42%
5. Dividend
5.1 Amount
CNMD has a Yearly Dividend Yield of 1.66%. Purely for dividend investing, there may be better candidates out there.
CNMD's Dividend Yield is rather good when compared to the industry average which is at 1.79. CNMD pays more dividend than 95.24% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.30, CNMD is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.66% |
5.2 History
The dividend of CNMD decreases each year by -0.01%.
CNMD has been paying a dividend for at least 10 years, so it has a reliable track record.
CNMD has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-0.01%
Div Incr Years0
Div Non Decr Years12
5.3 Sustainability
CNMD pays out 22.42% of its income as dividend. This is a sustainable payout ratio.
DP22.42%
EPS Next 2Y8.14%
EPS Next 3Y9.42%
NYSE:CNMD (10/28/2025, 2:22:15 PM)
47.11
-0.25 (-0.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners114.95%
Inst Owner Change1.26%
Ins Owners0.27%
Ins Owner Change-0.53%
Market Cap1.46B
Revenue(TTM)1.33B
Net Income(TTM)110.20M
Analysts73.33
Price Target62.99 (33.71%)
Short Float %6.82%
Short Ratio5.91
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.66% |
Yearly Dividend0.8
Dividend Growth(5Y)-0.01%
DP22.42%
Div Incr Years0
Div Non Decr Years12
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.57%
Min EPS beat(2)0.37%
Max EPS beat(2)14.78%
EPS beat(4)4
Avg EPS beat(4)7%
Min EPS beat(4)0.37%
Max EPS beat(4)14.78%
EPS beat(8)7
Avg EPS beat(8)4.79%
EPS beat(12)10
Avg EPS beat(12)-0.43%
EPS beat(16)13
Avg EPS beat(16)0.77%
Revenue beat(2)1
Avg Revenue beat(2)-0.12%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)0.51%
Revenue beat(4)1
Avg Revenue beat(4)-0.8%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)0.51%
Revenue beat(8)1
Avg Revenue beat(8)-1.21%
Revenue beat(12)3
Avg Revenue beat(12)-1.83%
Revenue beat(16)4
Avg Revenue beat(16)-1.82%
PT rev (1m)0%
PT rev (3m)-10.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.71%
EPS NY rev (1m)0%
EPS NY rev (3m)1.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.49 | ||
| Fwd PE | 9.68 | ||
| P/S | 1.1 | ||
| P/FCF | 9.84 | ||
| P/OCF | 8.83 | ||
| P/B | 1.45 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.78 |
EPS(TTM)4.49
EY9.53%
EPS(NY)4.87
Fwd EY10.33%
FCF(TTM)4.79
FCFY10.17%
OCF(TTM)5.34
OCFY11.33%
SpS42.85
BVpS32.4
TBVpS-13.11
PEG (NY)1.1
PEG (5Y)1.11
Graham Number57.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.73% | ||
| ROE | 10.99% | ||
| ROCE | 9.38% | ||
| ROIC | 7.55% | ||
| ROICexc | 7.68% | ||
| ROICexgc | 25.98% | ||
| OM | 14.38% | ||
| PM (TTM) | 8.31% | ||
| GM | 56.05% | ||
| FCFM | 11.18% |
ROA(3y)1.68%
ROA(5y)1.82%
ROE(3y)3.56%
ROE(5y)3.99%
ROIC(3y)5.34%
ROIC(5y)4.97%
ROICexc(3y)5.41%
ROICexc(5y)5.04%
ROICexgc(3y)20.03%
ROICexgc(5y)18.26%
ROCE(3y)6.64%
ROCE(5y)6.18%
ROICexgc growth 3Y14.62%
ROICexgc growth 5Y8.81%
ROICexc growth 3Y13.67%
ROICexc growth 5Y10.96%
OM growth 3Y13.68%
OM growth 5Y9.55%
PM growth 3Y17.89%
PM growth 5Y27.61%
GM growth 3Y-0.07%
GM growth 5Y0.25%
F-Score7
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.88 | ||
| Debt/FCF | 5.95 | ||
| Debt/EBITDA | 3.34 | ||
| Cap/Depr | 23.31% | ||
| Cap/Sales | 1.28% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.68% | ||
| Profit Quality | 134.53% | ||
| Current Ratio | 2.23 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.04 |
F-Score7
WACC6.37%
ROIC/WACC1.19
Cap/Depr(3y)25.34%
Cap/Depr(5y)23%
Cap/Sales(3y)1.54%
Cap/Sales(5y)1.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.38%
EPS 3Y9.03%
EPS 5Y9.44%
EPS Q2Q%17.35%
EPS Next Y9.58%
EPS Next 2Y8.14%
EPS Next 3Y9.42%
EPS Next 5YN/A
Revenue 1Y (TTM)3.94%
Revenue growth 3Y8.95%
Revenue growth 5Y6.47%
Sales Q2Q%3.09%
Revenue Next Year5.05%
Revenue Next 2Y5.25%
Revenue Next 3Y5.42%
Revenue Next 5YN/A
EBIT growth 1Y11.97%
EBIT growth 3Y23.86%
EBIT growth 5Y16.64%
EBIT Next Year45.54%
EBIT Next 3Y17.93%
EBIT Next 5YN/A
FCF growth 1Y832.34%
FCF growth 3Y16.67%
FCF growth 5Y15.46%
OCF growth 1Y345.31%
OCF growth 3Y14.3%
OCF growth 5Y11.92%
CONMED CORP / CNMD FAQ
What is the ChartMill fundamental rating of CONMED CORP (CNMD) stock?
ChartMill assigns a fundamental rating of 6 / 10 to CNMD.
What is the valuation status of CONMED CORP (CNMD) stock?
ChartMill assigns a valuation rating of 8 / 10 to CONMED CORP (CNMD). This can be considered as Undervalued.
How profitable is CONMED CORP (CNMD) stock?
CONMED CORP (CNMD) has a profitability rating of 8 / 10.
What is the valuation of CONMED CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for CONMED CORP (CNMD) is 10.49 and the Price/Book (PB) ratio is 1.45.
How financially healthy is CONMED CORP?
The financial health rating of CONMED CORP (CNMD) is 4 / 10.